Disposable Syringe Market Size, Demand and Production Forecasts to 2023

Feb 24, 2020: The global disposable syringe market is expected to register a robust CAGR during the forecast period. Syringe is a medical instrument for injecting any fluid in form of medicine into the body of human beings or any other animal. Technically, it consists of an airtight piston and a round cylinder. The medicines that need intravenous route of administration for medicines that cannot be taken orally or mixing with food.

Glass was used in the early days for production of these syringes, which was commonly known as Pyrex glass. At present, disposable syringes are made of polypropylene and are available in various sizes. Since, plastic has gained a lot of prominence; it is a proven substitute for glass and helps in saving natural resources. Therefore, constant development in polymer technology, cost effective production and processing machinery has helped the disposable syringes market to grow by leap and bounds.

Request a Free Sample Copy of Disposable Syringe Market Report @  https://www.radiantinsights.com/research/global-disposable-syringe-market-outlook-2018-2023/request-sample

Disposable syringe market is driven by rise in demand for injectable drugs. Increase in R&D activities and development of self-injection devices with high efficiency is likely to enhance the market growth during the forecast period. Investment by industry players for biologics and surge in demand is more likely to propel the market growth during the forecast period. Biologics have a prominent position in the medical field owing to their features and advantages.

By type, the disposable syringe market is segmented as safety syringes and conventional syringes. Application category is bifurcated as therapeutic injections and immunization injections. By product categorization, the market comprises retractable and non-retractable products. Non-retractable products are likely to gain a higher position during the prediction period.

Geographical segmentation for disposable syringe market report are North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America accounts for a significant market share during the forecast period due to higher prevalence of chronic disease and rise in preference for injectable drugs. Introduction of new drugs and technologies are more likely to propel the market growth.

For further inquiries, about - Global Disposable Syringe Industry Analysis, Size, Growth, Trends and Forecast 2018 - 2023, click on this link – https://www.radiantinsights.com/research/global-disposable-syringe-market-outlook-2018-2023

European market houses majority of the key players and hence there exists a robust regulatory framework for drugs and medicine. Moreover, European governments have necessitated the use of engineered devices in medical and healthcare facilities resulting in high standards for patient safety by healthcare personnel. The key players profiled in the disposable syringe market report are Flextronics International Vita and Braun Medical Inc.

Global Market for disposable syringe to 2023 offers detailed coverage of disposable syringe industry and presents main market trends. The market research gives historical and forecast market size, demand and production forecasts, end-use demand details, price trends, and company shares of the leading disposable syringe producers to provide exhaustive coverage of the disposable syringe.

Report contents include
- Analysis of the disposable syringe market including revenues, future growth, market outlook
- Historical data and forecast
- Regional analysis including growth estimates
- Analyzes the end user markets including growth estimates.
- Profiles on disposable syringe including products, sales/revenues, and market position
- Market structure, market drivers and restraints.

To read more reports of this category, Visit our blog:  https://healthandpharamceuticalri.blogspot.com

 Key regions
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South America

Key vendors
- request free sample to get a complete list of companies

Inflammatory Bowel Disease Treatment Market Will Have Positive Impact Due To Growing Geriatric Population

Feb 18, 2020: The global inflammatory bowel disease treatment market size is expected to reach USD 22.4 billion by 2026, according to a new report by Grand View Research, Inc., registering a 4.4% CAGR during the forecast period. Increasing prevalence and incidence of Crohn's disease and ulcerative colitis is one of the major factors contributing to the market.

According to a study published in the NCBI in 2019, the North America incidence of inflammatory bowel disease (IBD) treatment is around 2.2 to 19.2 cases per 100,000 persons per year. It was also published that around 238 per 100,000 populations in U.S. were suffering from ulcerative colitis. Furthermore, The Centres for Disease Control and Prevention (CDC) estimates that in U.S., every year nearly 1-1.3 million people suffer from inflammatory bowel disease.

Request a Free Sample Copy of Inflammatory Bowel Disease Treatment Market Report @  https://www.radiantinsights.com/research/inflammatory-bowel-disease-treatment-market/request-sample

In addition, involvement of regulatory bodies for funding and designation is expected to propel the growth of the market. For instance, the Crohn's and Colitis Foundation offers grants and fellowships for research on inflammatory bowel disease (includes Crohn's disease and ulcerative colitis).

Growing geriatric population is expected to positively impact the overall market. According to an article published in 2018 in the United States Census Bureau, it is estimated that by 2035, the population aged 65 years and above is expected to reach 78 million, whereas children under the age of 18 might be around 76.7million.

Moreover, companies such as Johnson & Johnson Services Inc.; Pfizer Inc.; Takeda Pharmaceutical Company Limited; and AbbVie Inc. are majorly involved in product research and development and this is also considered as one of the major driving factors for the market.

For further inquiries, about - Global Inflammatory Bowel Disease Treatment Industry Analysis, Size, Growth, Trends and Forecast 2019 - 2026, click on this link – https://www.radiantinsights.com/research/inflammatory-bowel-disease-treatment-market

Further key findings from the report suggest:

• The global inflammatory bowel disease treatment market is anticipated to reach USD 22.4 billion by 2026, exhibiting a CAGR of 4.4% from 2018 to 2026

• Crohn's disease dominated the market by type in 2018 due to increasing incidence of the disease. On the other hand, ulcerative colitis was estimated to be the fastest growing segment owing to presence of strong pipeline products for its treatment

• By route of administration, injectables dominated the IBD treatment market in 2018 while oral was estimated to be the fastest growing segment over the forecast period

• Aminosalicylic acid (ASAs) was considered to be the largest oral segment in 2018 and JAK inhibitors to be the fastest growing segment

• In 2018, TNF-inhibitors dominated the injectables segment while anti-integrins are estimated to be the fastest growing segment

• Hospital pharmacy was the largest segment in 2018 with a market share of 36.6% and online pharmacy was anticipated to be the fastest owing to the comfort, flexibility and convenience provided

• North America held the dominant share in 2018 owing to presence of key companies in this region. Asia Pacific, on the other hand, was estimated to be the fastest growing region

• Some of the key companies operating in this inflammatory bowel disease treatment market are Johnson & Johnson Services Inc.; Pfizer Inc.; Takeda Pharmaceutical Company Limited; AbbVie Inc.; Celltrion Healthcare Co., Ltd.; CELGENE CORPORATION; COSMO PHARMACEUTICALS; Innovate Biopharmaceuticals; UCB S.A.; and Gilead Sciences.

Microscope Market Will Rise as Growing Demand for Advanced and High Resolution Microscopes

June 12, 2019: The global microscope market size is expected to reach USD 15.1 billion by 2026 registering a CAGR of 7.9%. Growing demand for advanced and high resolution microscopes for conducting R&D in the fields, such as life sciences and nanotechnology, is expected to drive the market over the forecast period. Emergence of new application areas, such as quantum dots and miniature transistor chips, will further boost the market growth. Quantum dots technology is currently in a nascent stage and is expected to cater to multiple application areas including in transistors, diode lasers, quantum computing, biological imaging, solid-state lighting, electroluminescent displays, and photo-voltaic cells. Optical devices led the market in 2018, owing to their large application base. However, due to high adoption of advanced microscopes, scanning probe and electron microscopes are expected to gain share over the coming years.

Request a Free Sample Copy of Microscope Market Report @  https://www.radiantinsights.com/research/microscopes-market/request-sample

Scanning probe devices is expected to be the fastest-growing product segment from 2019 to 2026. Features, such as non-dependence on wavelength of the source light, resolving atoms, and generating better 3D maps of surfaces, are some of the factors expected to drive the demand of these products. North America led the global market, in terms of revenue, in 2018 and is likely to reach USD 4.7 billion by 2026.

Further key findings from the study suggest:

• Semiconductors and life sciences were the dominant application segments in the global microscope market

• However, nanotechnology is expected to be the fastest-growing application with a CAGR of 9.3% from 2019 to 2026

• Asia Pacific is expected to be the fastest-growing regional market with a CAGR of 9.1% from 2019 to 2026

• High demand for semiconductors and positive outlook on application markets are expected to be the key drivers responsible for the market growth in the region

• Key companies in the market include Olympus Corporation, Hitachi High-Technologies Corporation, Nikon Corporation, FEI Company, JEOL Ltd., Carl Zeiss, and Leica Microsystems

For further inquiries, about - Global Industry Analysis, Size, Growth, Trends and Forecast 2019 - 2026, click on this link – https://www.radiantinsights.com/research/microscopes-market

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Applications
1.1.3 Regional scope
1.1.4 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR's internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Latin America
1.3.5.5 Data for Primary interviews in MEA
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis (Model 1)
1.6.1.1 Approach 1: Commodity flow approach
1.6.2 Volume price analysis (Model 2)
1.6.2.1 Approach 2: Volume price analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Objectives
1.9.1 Objective 1:
1.9.2 Objective 2:

To read more reports of this category, Visit our blog:  https://healthcarepharmamedicaldevices.home.blog

About Radiant Insights, Inc

Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.

Medical Oxygen Concentrators Market Will Boost Due To Rising Prevalence Of Respiratory Diseases

June 11, 2019: The global medical oxygen concentrators market size is projected to reach at USD 2.88 billion expanding at a CAGR of 7.4. Key factors boosting the market include rising prevalence of Chronic Obstructive Pulmonary Disease (COPD) and other respiratory diseases and increasing geriatric population, which is highly susceptible to chronic diseases. In addition, constant technological advancements in the field is likely to drive the market further.

Request a Free Sample Copy of Medical Oxygen Concentrators Market Report @  https://www.radiantinsights.com/research/medical-oxygen-concentrators-market/request-sample

According to data published by the United Nations, global geriatric population is expected to increase from 962 million in 2017 to 2.1 billion by 2050. Based on product type, the market is classified into portable and stationary oxygen concentrators. The portable product segment is expected to register the highest CAGR over the forecast period on account of increasing target population base, rising cases of COPD, and demand for lightweight and portable concentrators. Advantages offered by these produces, such as smaller size and improved portability, are also likely to augment their demand over stationary devices.

On the basis of application, the market is classified into homecare and non-homecare. Homecare was the dominant segment in 2018 and is anticipated to expand at the fastest CAGR from 2019 to 2025. This is attributed to the factors, such as growing geriatric population and increasing demand for healthcare oxygen therapies. Homecare oxygen concentrators provide independence of use, which allow patients to complete their day-to-day activities with ease, this is also said to boost their demand. Asia Pacific is anticipated to be the fastest-growing regional market at a CAGR of 8.3% from 2019 to 2025.

Download Full Research Report on “Medical Oxygen Concentrators Market” @  https://www.radiantinsights.com/research/medical-oxygen-concentrators-market

Further key findings from the study suggest:
• Portable devices led the global medical oxygen concentrators market in 2018 owing to their advantages over the stationary devices
• Homecare was the dominant application segment in 2018 owing to increased geriatric population, prevalence of COPD, and need for homecare oxygen therapies
• North America led the global market with a revenue of USD 687.9 million in 2018 and is anticipated to maintain its dominance over the forecast period
• This is growth is attributed to the developed homecare and healthcare services and favorable reimbursement policies in the region

• Key companies in the market are Invacare Corp.; Drive DeVilbiss Healthcare, Inc.; Philips Healthcare; Nidek Medical; Covidien Ltd.; AirSep Corporation; Inogen, Inc.; and ResMed

Dental Equipment Market Will Rise Due To Increased Awareness Regarding Dental Hygiene

June 10, 2019: The global dental equipment market size is expected to reach USD 10.47 billion by 2025, it is anticipated to expand at a lucrative CAGR of 4.5% over the forecast period. Key factors attributed to the growth include increasing demand for dental procedures owing to prevalence of dental disorders and rising awareness and demand for preventive, restorative, and surgical services for dental care. Moreover, favorable government initiatives regarding dental hygiene is also a significant factor responsible for driving the market. Due to increasing number of initiatives, there is an increase in awareness regarding dental hygiene leading to increasing adoption of dental treatments, which in turn is anticipated to drive the market for dental equipment over the forecast period.

Dental equipments are classified on the basis of product into dental radiology, dental lasers, systems and parts, laboratory machines, hygiene equipment, and others. The systems and parts segment held the leading market share of 39.9% in 2018 and is anticipated to grow at a lucrative pace over the forecast period. The segment is further classified into instrument delivery systems, vacuums and compressors cone beam CT systems, cast machines, furnace and ovens, CAD/CAM, and electrosurgical equipment. The CAD/CAM sub-segment led in 2018 owing to the technological superiority of these equipment over traditional die casting techniques.

Request a Free Sample Copy of Dental Equipment Market Report @   https://www.radiantinsights.com/research/dental-equipment-market/request-sample

North America led with a market share of 29.6% in 2018. Some of the key reasons attributed to the high share include technological advancements, rising demand for dental surgeries, growing geriatric population, and increasing number of dentists and dental clinics. On the other hand, Asia Pacific is expected to expand at the fastest CAGR of 4.9% over the forecast period. Constantly developing healthcare infrastructure and increasing healthcare expenditure coupled with the presence of high unmet medical needs are expected to serve this market as high-impact rendering drivers.

Few significant companies venturing in the market include, Denstply International Inc.; A-Dec Inc.; Planmeca Oy; Sirona Dental Systems Inc.; Patterson Companies Inc.; Straumann; GC Corporation; Carestream Health Inc.; Biolase Inc.; Danaher Corporation; and 3M.

Further key findings from the report suggest:
• Systems and parts product segment led the market in 2018 and is anticipated to grow at a lucrative rate over the forecast period
• CAD/CAM sub-segment of systems and parts accounted for the largest market share in terms of revenue in 2018, owing to technological advancements
• North America led the dental equipment market in 2018 with a revenue share of USD 1.84 billion owing to the presence of advanced healthcare facilities and strong reimbursement scenarios
• Some of the key players operating in the market are, Cook Medical; Smiths Medical; Edwards Life Sciences Corporation; Medtronic Inc.; and Johnson & Johnson.

The report “Dental Equipment Market to 2025” is available now at  https://www.radiantinsights.com/research/dental-equipment-market

About Radiant Insights, Inc
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.

Home Infusion Therapy Market Size Is Expected To Reach USD 38.7 Billion By 2026

June 07, 2019: The global home infusion therapy market size is expected to reach USD 38.7 billion by 2026 registering a CAGR of 7.2% from 2019 to 2026, according to a new report by Radiant Insights, Inc. Rapid technological advancements are some major factors contributing to the market growth. Home infusion is gradually being considered as an alternative to extended stay in hospitals or nursing homes for patients suffering from chronic diseases. With the administration of medications in home settings, patients recover faster, are more comfortable, and save money. Several government and non-government programs aimed at reducing the burden of hospital stays by establishing infusion centers that provide quick IV infusion services are likely to have a positive impact on the market.

Request a Free Sample Copy of Home Infusion Therapy Market Report @  https://www.radiantinsights.com/research/home-infusion-therapy-market/request-sample

Furthermore, favorable government policies and regulations are expected to propel the industry growth. In addition, rising prevalence of diseases, such as Cardiovascular Diseases (CVDs), cancer, diabetes, and other life-threatening conditions, is expected to be a high impact rendering driver for the market. According to the WHO, at present, all the aforementioned diseases account for 60% of total deaths and 43% of the disease burden in U.S. This creates the need to infuse nutritional products that contain glutamine, phospholipids, glucose, and amino acids, which in turn, is expected to boost the market growth in the region.

Further key findings from the study suggest:

• Infusion pumps led the product segment in 2018 owing to their extensive use for the delivery of fluids, such as medications and nutrients, during infusion therapy

• Needleless connectors is the fastest-growing product segment over the forecast period. These devices provide protection from needlestick injuries

• Anti-infective segment held the largest share in 2018 owing to a large number of procedures performed for administering antibiotics and antifungals

The report “Home Infusion Therapy Market Size, Share & Trends Analysis Report” is available now at https://www.radiantinsights.com/research/home-infusion-therapy-market 

• The chemotherapy segment is expected to witness lucrative growth during the forecast period on account of initiatives undertaken pertaining to cancer treatment, such as development of infusion centers by the Cancer Treatment Centers of America

• The market is highly competitive and is marked by the presence of key companies, such as B. Braun Melsungen AG; ICU Medical, Inc.; Baxter; Fresenius Kabi AG; Caesarea Medical Electronics; Terumo Corporation; CareFusion Corporation; JMS Co. Ltd.; and Smiths Medical

• Most of these companies focus on new product development to maintain their position in the global home infusion therapy market

Immuno-Oncology Market Will Grow Due to Rise in Cancer Patients and Favorable Reimbursements

May 06, 2019: The global immune-oncology market is anticipated to rise at a significant CAGR in the forecast period. Immune-oncology market is driven by factors such as manufacturers’ emphasis on upgrading immune-oncology drugs as well as increase in R&D to develop anti-cancer drugs. Development of innovative products coupled with product launches is anticipated to propel market growth soon. Increasing advances in healthcare settings and use of innovation in medical sector are now emphasizing better services to offer to cancer patients, which in turn has bolstered the immune-oncology market.


By Type, the immune-oncology market segmentation includes mAb (Naked, Conjugate), Cancer Vaccines and Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4). By Application, the immune-oncology market is segmented as Lung, Melanoma, Leukemia, and Lymphoma. Leukemia and lymphoma account for a higher market due to rise in prevalence and low medical attention. Lung diseases witnessed a remarkable CAGR due to rise pollution and change in lifestyle.


Request a Free Sample Copy of Immuno-Oncology Market Report @  https://www.radiantinsights.com/research/immuno-oncology-market/request-sample


Geographical segmentation for immune-oncology market includes North America, Latin America, Europe, Middle East, Asia-Pacific and Middle East and Africa. North America dominates the market growth in the global scenario owing to rise in improvements in healthcare settings and improved medical care. Advances in medicines and mode of drug administration also propels the growth of U.S. market. European market is expected to follow the same trend with a slight difference of reimbursement scenario. Favorable reimbursement for medical and cancer cases fuels the market.

Asia-Pacific regions account for a significant market share in the global scenario rise in cancer patients and favorable reimbursements. Prominent players in the immune-oncology market include Amgen, Inc. AstraZeneca Plc, Bristol-Myers Squibb, Celgene Corporation, Pfizer Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis International AG, AbbVie, Inc., Eli Lilly and Company, Merck & Co., Prometheus Therapeutics & Diagnostics, Sanofi S.A., EMD Serono, Inc., Aduro BioTech, Galena Biopharma, Bavarian Nordic, Celldex Therapeutics, ImmunoCellular Therapeutics, Gilead Sciences Inc. and Incyte.


Immuno-oncology is a unique approach that uses the body’s immune system to fight cancer. These therapies activate an individual’s immune system, making it able to recognize cancer cells and destroy them. Immuno-oncology therapies provide long lasting anti-cancer benefits to patients who previously had very few treatment options available to them. These therapies work against a large number of cancer types. The technological advancements are helping the growth of immuno-oncology market. The biotechnology and pharmaceutical companies are striving to launch new and most effective therapies.


The report “Immuno-Oncology Market Report” is available now at  https://www.radiantinsights.com/research/immuno-oncology-market


According to the report “Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4]), By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to 2022”, the global immuno-oncology market is anticipated to cross US$ 100 Billion by 2022. The report provides a detailed analysis of the global immuno-oncology market. The report also provides the current and forecasted market for immuno-oncology.


Furthermore, the report provides insights about the major drivers and challenges, along with the latest trends and developments impacting the industry growth. In addition, the report also highlights various opportunities available for growth of the global immuno-oncology market. Moreover, the report provides the sales of major marketed immuno-oncology drugs.


The global immuno-oncology market has been segmented on the basis of type of product into monoclonal antibodies, therapeutic vaccines, and immune checkpoint inhibitors amongst others. According to the report, monoclonal antibodies segment was estimated to account for the largest share in 2016 due to rising prevalence of cancer & rising usage in a number of therapies (antibody-directed enzyme pro-drug therapy and radio immunotherapy).


The report also sheds light on the geographic segmentation of the global immuno-oncology market. In 2016, North America was estimated to account for the largest share. Presence of major players, increased awareness and better distribution mechanisms are some of the prominent factors that have led to North America being the market leader.


Based on type of cancer, the immuno-oncology market is dominated by Lung Cancer & Melanoma applications with several companies and academic institutions focusing on novel treatment approaches, thus making the major contribution to the global immuno-oncology market. The report provides the market analysis of major indications along with the forecast till 2022.


A major focus has been on the ongoing clinical trials for the development of innovative products. In this context, the report provides information about the immuno-oncology programs at various stages of clinical development. In addition, the report highlights the strategic collaborations amongst the players for enhancing their market share.





The later part of the report discusses some of the prominent players in the global immuno-oncology market. Market share analysis of major players is also provided in the report. Furthermore, a brief business overview of each player has been provided along with their product and pipeline portfolios and recent developments. Overall, immuno-oncology is an important and rapidly emerging field. This report will prove as a complete source of knowledge and analysis for clients and potential investors.